ARTICLE | Clinical News
HMS5552: Phase Ib started
March 31, 2014 7:00 AM UTC
Hua Medicine began a double-blind, placebo-controlled Phase Ib trial to evaluate multiple ascending-doses of 25-400 mg oral HMS5552 twice daily in about 50 patients. Hua Medicine has exclusive, worldw...